Alternatives to iThriveMD

Dose-scaling pricing from $189/mo (starting dose) up to $389/mo (top tirzepatide dose), confirmed by pulling the site's own production pricing and states data directly — genuinely specific 48-state coverage (all but AL and MS) and no hidden cancellation fee found in its own Refund Policy.

Flat compounded pricing with the post-introductory number actually printed: $149 a month for semaglutide and $229 for tirzepatide, the same at every dose, after intro rates of $119 and $199. For planning purposes that flatness is the useful part — a titration step-up does not change the bill, so the number you budget in month one is the number in month six. All 50 states, and consultation, prescription, medication, shipping and support are inside the price. Watch the word "from" on every figure: the site says dosage and titration can move what you pay.

The whole price table before you hand over a detail: $175/mo semaglutide with no commitment, flat at every dose. The advertised $146 is $875 prepaid for six months — and nothing renews on its own.

It shows both prices at once and says which is which: $149/mo with no commitment, $79 on a twelve-month plan. Brand-name is listed, but all three pages say coming soon.

One flat monthly charge with everything genuinely inside it — $199 and $269, no membership or consult fee — plus a published “prescribed today, delivered in two days.”

Telehealth GLP-1 programs in all 50 states from $149 a month, including a dedicated microdose protocol alongside standard semaglutide and tirzepatide. That figure is a floor rather than a rate, it is labeled a limited-time offer, and no treatment page publishes a price for any specific molecule, so the real cost is not knowable until you finish a two-minute eligibility check. Superior Remedies charges nothing if you are not approved, titrates the dose to how you respond rather than shipping a fixed refill, and attributes its compounding to state-licensed pharmacies it does not name.

AurenRx names both the practice that prescribes and the pharmacy that compounds, with addresses — Wasef Health, PC c/o Michael Wasef MD in Pinellas Park, Florida, and VialsRX in Houston, Texas — and the prescriber's details match the federal NPI registry exactly. It charges the same for either molecule, which is genuinely unusual: $259 a month on a recurring plan or $299 with no commitment, for semaglutide or tirzepatide alike, plus a low-and-slow microdose track at $229/$250. Everything is included in that price, the online visit is free, and the LegitScript badge it displays is real. The problem is its own front page. AurenRx advertises its GLP-1 and Microdose programs at 'from $129/mo' on the homepage, while the cheapest thing you can actually buy on the product page is $229 — nothing costs $129. That is not a promotion that expired or a plan you have to hunt for; it is roughly half the real price, sitting on the page most readers see first.

The Edit is one of the very few providers on this page that names both the medical practice writing your prescription and the pharmacy compounding it — Arora Health & Aesthetics, LLC and The Pharmacy Hub — rather than gesturing at 'licensed US providers'. Compounded semaglutide is $209 a month and tirzepatide $309, the same price at every dose, with the prescription, all injection supplies, the clinician visit and temperature-controlled two-day shipping inside that one number and no membership fee on top. First orders are $100 off, and three- and six-month plans bring the per-month equivalent down to $192 and $178 for semaglutide. It covers all 50 states and, unusually for this market, runs a complete Spanish-language version of the site rather than a machine-translated shim. The limits are real but narrow: it is compounded-only, so there is no FDA-approved Wegovy or Zepbound here, and there is no postpartum, breastfeeding or PCOS guidance anywhere on the site.

$199/mo semaglutide, $299/mo tirzepatide, three named co-founders, no contracts, a claimed ~24-hour NP review, and no live video visit described anywhere in the flow — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, plus no pharmacy named and no state list disclosed. That combination — real speed and a named founding team, next to an overstated regulatory badge and thin disclosure elsewhere — is why Spry lands in the middle of the pack rather than near the top on this site's Rx-Readiness scorecard.